A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation
Clinical trial NCT04201418 · COMPLETED
Trial details
- NCT number
- NCT04201418
- Sponsor
- Alnylam Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-12-18
- Primary completion
- 2022-05-24
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.